Analysing cell death patterns to predict outcomes and treatment options in patients with high-grade serous ovarian carcinoma

分析细胞死亡模式以预测高级别浆液性卵巢癌患者的预后和治疗方案

阅读:2

Abstract

High-grade serous ovarian carcinoma (HGSOC) is a gynaecological malignancy that is often fatal. Poor prognosis of HGSOC patients is primarily attributed to concealed initial symptoms, diagnostic challenges, postsurgical recurrence , and chemoresistance. Distinct programmed cell death (PCD) patterns play a pivotal role in tumour progression, serving as valuable predictors for postoperative intervention outcomes in HGSOC. Additionally, they provide insights into HGSOC’s pathogenesis and the exploration of immunomodulatory therapeutic mechanisms. Transcriptome and clinical data were collected from TCGA-OV and the GSE26193 databases. We constructed an ovarian carcinoma death score intervention model using eight genes and machine learning algorithms based on 13 PCD modes (apoptosis, necroptosis, pyroptosis, cuproptosis, ferroptosis,entotic cell death, netotic cell death, parthanatos, lysosome-dependent cell death, autophagy, alkaliptosis, oxeiptosis, and disulfidptosis). Three molecular subtypes of HGSOC with different biological processes were identified using unsupervised clustering models. A nomogram was constructed by combining the cell death index (CDI) with clinical features, which exhibited high predictive performance. The correlation between CDI and immune checkpoint genes, components within the tumour microenvironment, and drug therapy sensitivity was analysed. After multiple dataset validation, the prognosis of HGSOC patients with high CDI was relatively poor. CDI and immune checkpoint genes were related to components of the tumour microenvironment. Patients with HGSOC and high CDI may have resistance to standard adjuvant therapy; therefore, targeting these genes could be a potential therapeutic strategy. Finally, we found that our model had better predictive ability than published models. We conducted a comprehensive analysis of 13 PCD patterns and established a novel CDI model, which can evaluate the prognosis of HGSOC and provide a theoretical basis for its clinical treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-42628-3.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。